According to the agreement, Sanyou Bio will upgrade the development process through automation, substantially reducing the R&D timeline for innovative drugs. Through this strategic cooperation, Sanyou ...

Key opportunities in the preclinical CRO market lie in outsourcing R&D to streamline drug discovery and cut costs, with significant growth in AI-driven drug discovery. North America dominates, with ...

POTOMAC, MARYLAND / ACCESS Newswire / / IGC Pharma, Inc. ("IGC Pharma," "IGC," or the "Company") (NYSE American:IGC), a ...

POTOMAC, MARYLAND / ACCESS Newswire / November 3, 2025 / IGC Pharma, Inc. ("IGC Pharma," "IGC," or the "Company") (NYSE American:IGC), a clinical-stage biotechnology company leveraging AI to develop i ...

Explore the innovative Willow quantum chip by Google, marking a major milestone in quantum computing with 13,000× faster ...

IIT-Madras introduces 'PURE', a groundbreaking AI framework streamlining drug discovery by efficiently generating synthesisable drug-like molecules. Developed with Ohio State University, PURE uses ...

IIT Madras announces the 'PURE' AI framework, promising significant reductions in drug development timelines. Developed with Ohio State University, PURE uses reinforcement learning to optimize ...

IIT-M and Ohio State researchers develop PURE, an AI framework that accelerates drug development by mimicking real-time chemical synthesis.

The healthtech industry is on track to triple from $352 in 2025 to over $1.1T by 2032, driven by critical needs in provider capacity, aging populations, and chronic disease management.

IGC Pharma (IGC) announced an expansion of its AI-powered in-Silico drug discovery platform. The company is now integrating more methodologies, ...

Stay on top of current hot topics through free webinars presented by leading experts in the pharma, biotech, medical device and food industries. Access to all webinars is free, so be sure to register ...

NurExone’s U.S. subsidiary, Exo-Top Inc., is advancing plans for the establishment of a GMP-compliant facility dedicated to naive exosome production. The Company believes participation in ARMI’s ...